The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants
- 1 November 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 39 (11), 877-882
- https://doi.org/10.1111/j.2042-7158.1987.tb03121.x
Abstract
Structure-activity relationships for 25 structural variants around the 5-hydroxytryptamine (5-HT) uptake inhibitors paroxetine and femoxetine have been investigated. Three parameters related to the 5-HT system were investigated: (i) The inhibition of [3H]5-HT uptake into rat brain synaptosomes, (ii) the inhibition of [3H]paroxetine binding to rat neuronal membranes and (iii) the effect of the compounds on the affinity of [3H]imipramine for the human platelet membrane binding site, measured as the dissociation rate of the [3H]imipramine human platelet membrane binding site complex. A highly significant correlation was found for 5-HT uptake inhibition and inhibition of [3H]paroxetine binding for the different substances, indicating that the two parameters are closely connected. However the slope of the regression line was only 0ṁ6 and not 1ṁ0; this may indicate that [3H]paroxetine binding is necessary, but not sufficient for 5-HT uptake inhibition. No correlation was found between the inhibition of [3H]paroxetine binding and the affinity of the compounds for the [3H]imipramine binding site complex. The two binding sites are therefore probably situated on different parts of the 5-HT transport system, the [3H]paroxetine binding site being part of the 5-HT transport mechanism whereas the [3H]imipramine binding site may represent a site modulating the activity of, and affinity for, 5-HT in the 5-HT transport mechanism. Structure-activity relationships among the substances showed that stereochemical changes from (-)- to (+)-trans changed the activity towards both 5-HT uptake inhibition and [3H]paroxetine displacement for most of the (-)-/(+)-pairs. The substitution of —H with —F or —CH3 also affected the activity. The results showed that in this series of compounds, (-)-trans-4-(p-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine (paroxetine) is an optimal structure for influencing the chosen parameters.This publication has 15 references indexed in Scilit:
- Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranesEuropean Journal of Pharmacology, 1984
- Imipramine binding site Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Benzodiazepine receptor ligands with positive and negative efficacyNeuropharmacology, 1983
- High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranesEuropean Journal of Pharmacology, 1983
- High-Affinity [ 3 H]Imipramine Binding in Rat Hypothalamus: Association with Uptake of Serotonin But Not of NorepinephrineScience, 1980
- Demonstration of specific “high affinity” binding sites for [3H] imipramine on human plateletsLife Sciences, 1980
- (1S,3R,4S)-1-Methyl-3-(4-methoxyphenoxymethyl)-4-phenylpiperidinium chloride (FG4963): a selective inhibitor of serotonin uptakeActa crystallographica Section B, Structural science, crystal engineering and materials, 1979
- Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitorsEuropean Journal of Pharmacology, 1978
- A simplification of the protein assay method of Lowry et al. which is more generally applicableAnalytical Biochemistry, 1977
- Optical Isomerism and Pharmacological Action, a GeneralizationScience, 1956